Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
344781por Lund, Hans, Robinson, Karen A., Gjerland, Ane, Nykvist, Hanna, Drachen, Thea Marie, Christensen, Robin, Juhl, Carsten Bogh, Jamtvedt, Gro, Nortvedt, Monica, Bjerrum, Merete, Westmore, Matt, Yost, Jennifer, Brunnhuber, Klara“…ELIGIBILITY CRITERIA: Meta-research studies (empirical studies) were eligible if they evaluated whether redundancy was present and to what degree; whether health researchers referred to all earlier similar studies when justifying and designing a new study and/or when placing new results in the context of earlier similar trials; and whether health researchers systematically and transparently considered end users’ perspectives when justifying and designing a new study. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344782por Gobom, Johan, Benedet, Andréa L., Mattsson-Carlgren, Niklas, Montoliu-Gaya, Laia, Schultz, Nina, Ashton, Nicholas J., Janelidze, Shorena, Servaes, Stijn, Sauer, Mathias, Pascoal, Tharick A., Karikari, Thomas K., Lantero-Rodriguez, Juan, Brinkmalm, Gunnar, Zetterberg, Henrik, Hansson, Oskar, Rosa-Neto, Pedro, Blennow, Kaj“…Simultaneous antibody-free measurement of pTau epitopes by mass spectrometry avoids possible bias caused by differences in antibody affinity for modified or processed forms of tau, provides insights into tau pathophysiology and may facilitate clinical trials on tau-based drug candidates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-022-00586-0.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344783por van Vliet, Iris M.Y., Post, Adrian, Kremer, Daan, Boslooper‐Meulenbelt, Karin, van der Veen, Yvonne, de Jong, Margriet F.C., Pol, Robert A., Jager‐Wittenaar, Harriët, Navis, Gerjan J., Bakker, Stephan J.L., Dijkstra, G., de Meijer, V.E., Leuvenink, H.G.D., Bakker, S.J.L., Gan, C.T., Sanders, J.S.F., Verschuuren, E.A.M., Damman, K., Lexmond, W.S., Blokzijl, J., de Borst, M.H., Erasmus, M.E., Porte, R.J., de Boer, M.T., Pol, R.A., Berger, S.P., Eisenga, M.F., Neto, A.W. Gomes, Kremer, D., van Londen, M., Jong, J.H. Annema‐de, Siebelink, M.J., van Pelt, L.J., Niesters, H.G.M., Bodewes, F.A.J.A., Hepkema, B.G., Ranchor, A.V., Douwes, R.M.“…METHODS: Data of outpatient KTR ≥ 1 year post‐transplantation, included in the TransplantLines Biobank and Cohort Study (ClinicalTrials.gov Identifier: NCT03272841), were used. Muscle mass was determined as appendicular skeletal muscle mass indexed for height(2) (ASMI) through bio‐electrical impedance analysis (BIA), and by 24‐h urinary creatinine excretion rate indexed for height(2) (CERI). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344784por Kaura, A, Sterne, J A C, Trickey, A, Mulla, A, Glampson, B, Davies, J, Woods, K, Panoulas, V, Shah, A D, Patel, R S, Kharbanda, R, Shah, A M, Perera, D, Channon, K M, Mayet, J“…The SENIOR-NSTEMI Study showed a survival advantage of invasive compared with non-invasive management of elderly patients with NSTEMI, who were underrepresented in previous trials. The inverted U-shaped relationship between troponin and mortality in ACS patients in the TROP-RISK Study demonstrates that assembling sufficiently large datasets can cast light on patterns of disease that are impossible to adequately define in single centre studies. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344785por Nicholson, Tamaryn J, Hoddinott, Graeme, Seddon, James A, Claassens, Mareli M, van der Zalm, Marieke M, Lopez, Elisa, Bock, Peter, Caldwell, Judy, Da Costa, Dawood, de Vaal, Celeste, Dunbar, Rory, Du Preez, Karen, Hesseling, Anneke C, Joseph, Kay, Kriel, Ebrahim, Loveday, Marian, Marx, Florian M, Meehan, Sue-Ann, Purchase, Susan, Naidoo, Kogieleum, Naidoo, Lenny, Solomon-Da Costa, Fadelah, Sloot, Rosa, Osman, Muhammad“…We included randomised control trials (RCTs), case control, cross sectional, retrospective, and prospective cohort studies where TB mortality was a primary endpoint and effect measure estimates were provided for risk factors for TB mortality during TB treatment. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344786por Koltai, Mihaly, Moyes, Jocelyn, Nyawanda, Bryan, Nyiro, Joyce, Munywoki, Patrick K., Tempia, Stefano, Li, Xiao, Antillon, Marina, Bilcke, Joke, Flasche, Stefan, Beutels, Philippe, Nokes, D. James, Cohen, Cheryl, Jit, Mark“…Maternal vaccine (MV) and next-generation monoclonal antibody (mAb) candidates have been shown to reduce RSV disease in infants in phase 3 clinical trials. The cost-effectiveness of these biologics has been estimated using disease burden data from global meta-analyses, but these are sensitive to the detailed age breakdown of paediatric RSV disease, for which there have previously been limited data. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344787por Siristatidis, C., Papapanou, M., Karageorgiou, V., Martins, W. P., Bellos, I., Teixeira, D. M., Vlahos, N.“…METHODS: A literature search was performed in PubMed, Scopus and CENTRAL and registers for ongoing studies, from inception to February 2022, for randomized controlled trials (RCTs) with any sample size and observational studies including at least 100 live births per group, comparing the rates of any congenital anomaly and perinatal outcome of pregnancy following fresh/frozen embryo transfer at cleavage (day 2–3) vs blastocyst (day 5–7) stage. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344788por Strezova, Ana, Diez-Domingo, Javier, Shawafi, Kamal Al, Tinoco, Juan Carlos, Shi, Meng, Pirrotta, Paola, Mwakingwe-Omari, Agnes“…We have previously shown that RZV demonstrated high VE against HZ in adults ≥ 50 years of age (YOA) participating in 2 phase 3 clinical trials (ZOE-50, NCT01165177 and ZOE-70, NCT01165229), and VE persisted up to year (Y) 2 in the interim analysis of the extension study (ZOSTER-049, NCT02723773). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344789por Gupta, Meenakshi, Singh, Deepti, Rastogi, Shruti, Siddique, Hifzur R., Al-Dayan, Noura, Ahmad, Ajaz, Sikander, Mohammad, Sarwat, Maryam“…In vivo experiments and clinical trials are required to confirm the anticancer activity.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344790“…SELECTION CRITERIA: We included randomized controlled trials in children with severe dehydration due to acute diarrhoea comparing balanced solutions, such as Ringer's lactate or Plasma‐Lyte with 0.9% saline solution, for rapid rehydration. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344791“…METHODS: Mainstream oncology datasets and conferences were searched for randomized clinical trials (RCTs) published before August 2022. RCTs involved individuals with first line NSCLC treated with pembrolizumab monotherapy or in combination with chemotherapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344792por Novruzov, Emil, Giesel, Frederik L., Mori, Yuriko, Choyke, Peter L., Dabir, Mardjan, Mamlins, Eduards, Schmitt, Dominik, Antke, Christina, Pinto, Claudio, Soza-Ried, Cristian, Fernandez, Rene, Amaral, Horacio, Kramer, Vasko, Badinez, Leonardo“…However, there is limited data with (18)F-labeled FAP derivatives, i.e. [(18)F]FAPI-74, yet prospective single- and multicenter trials are already ongoing. In this proof-of-concept study, we sought to evaluate the biodistribution, tumor uptake, and lesion detectability in patients with PDAC using [(18)F]FAPI-74 PET/CT as compared to [(18)F]FDG PET/CT scans for staging. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344793por Xu, Shengshan, Chen, Xiguang, Fang, Jianxiong, Chu, Hongyu, Fang, Shuo, Zeng, Leli, Ma, Hansu, Zhang, Tianzhi, Chen, Yu, Wang, Tao, Zhang, Xin, Shen, Tao, Zheng, Youbin, Xu, Dongming, Lu, Zhuming, Pan, Yihang, Liu, Yuchen“…Based on data from several clinical trials, patients with LUAD, LUSC, SKCM, and BLCA who exhibited high SLC35A2 expression may experience improved immunotherapy response. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344794por Zhou, Jie, Singanayagam, Anika, Goonawardane, Niluka, Moshe, Maya, Sweeney, Fiachra P, Sukhova, Ksenia, Killingley, Ben, Kalinova, Mariya, Mann, Alex J, Catchpole, Andrew P, Barer, Michael R, Ferguson, Neil M, Chiu, Christopher, Barclay, Wendy S“…The study is registered with ClinicalTrials.gov, NCT04865237. FINDINGS: Between March 6 and July 8, 2021, 36 participants (ten female and 26 male) were recruited and 18 (53%) of 34 participants became infected, resulting in protracted high viral loads in the nose and throat following a short incubation period, with mild-to-moderate symptoms. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344795“…Eligibility Criteria The principal inclusion criteria consisted of randomized controlled trials evaluating protein or amino acid regimens as a measure to counteract muscle atrophy following orthopaedic surgery. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344796por MacLean, Elizabeth, Cisar, Laura, Mehle, Kimberly, Eremina, Daria, Quigley, Jane M.“…Although the efficacy and safety of axitinib have been established in clinical trials, information from real-world populations will help to elucidate patients' clinical profiles and utilization patterns. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344797por Amin, Alpesh, Keshishian, Allison, Trocio, Jeffrey, Dina, Oluwaseyi, Le, Hannah, Rosenblatt, Lisa, Liu, Xianchen, Mardekian, Jack, Zhang, Qisu, Baser, Onur, Nadkarni, Anagha, Vo, Lien“…Please see J Manag Care Spec Pharm, 2020;26(5):682 BACKGROUND: Clinical trials have shown that direct oral anticoagulants (DOACs)—including dabigatran, rivaroxaban, apixaban, and edoxaban—are at least as effective and safe as warfarin for the risk of stroke/systemic embolism (SE) and major bleeding (MB) in patients with atrial fibrillation (AF). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344798por Emmett, Susan D., Platt, Alyssa, Gallo, Joseph J., Labrique, Alain B., Wang, Nae-Yuh, Inglis-Jenson, Meade, Jenson, Cole D., Hofstetter, Philip, Hicks, Kelli L., Ross, Alexandra A., Egger, Joseph R., Robler, Samantha Kleindienst“…DESIGN: Hearing data were collected as part of two school-based cluster-randomized trials in 15 communities in rural northwest Alaska over two academic years (2017–2019). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344799por Morrison, Vicki A., Wong, Mitchell, Hershman, Dawn, Campos, Luis T., Ding, Beiying, Malin, Jennifer“…CONCLUSIONS: In this retrospective study of patients treated in 99 communityoncology practices, patients who received filgrastim often initiated treatment later than recommended and received fewer days per cycle than demonstrated to be effective in randomized controlled trials. Pegfilgrastim was generally initiated earlier within the course of chemotherapy compared with filgrastim, and because of its sustained duration of action, only a single injection was required. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344800por D'Souza, Anna O., Smith, Michael J., Miller, Lesley-Ann, Doyle, Joseph, Ariely, Rinat“…However, high discontinuation rates have been observed for these drugs in clinical trials, as well as in real-world settings, in part due to adverse effects. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto